PreprintCited by 150ECG Monitoring and AnalysisArtificial Intelligence in HealthcareArtificial Intelligence in Healthcare and Education

Detection of Left Ventricular Systolic Dysfunction from Electrocardiographic Images

Open access
Sangha, Veer, Nargesi, Arash A, Dhingra, Lovedeep S, Khunte, Akshay, Mortazavi, Bobak J, Ribeiro, Antônio H, Banina, Evgeniya, Adeola, Oluwaseun +12 more·2022·Circulation

Preprint — published as 10.1161/circulationaha.122.062646 · Paper page

Abstract

Background: Left ventricular (LV) systolic dysfunction is associated with over 8-fold increased risk of heart failure and a 2-fold risk of premature death. The use of electrocardiogram (ECG) signals in screening for LV systolic dysfunction is limited by their availability to clinicians. We developed a novel deep learning-based approach that can use ECG images for the screening of LV systolic dysfunction. Methods: Using 12-lead ECGs plotted in multiple different formats, and corresponding echocardiographic data recorded within 15 days from the Yale-New Haven Hospital (YNHH) during 2015-2021, we developed a convolutional neural network algorithm to detect LV ejection fraction < 40%. The model was validated within clinical settings at YNHH as well as externally on ECG images from Cedars Sinai Medical Center in Los Angeles, CA, Lake Regional Hospital (LRH) in Osage Beach, MO, Memorial Hermann Southeast Hospital in Houston, TX, and Methodist Cardiology Clinic of San Antonia, TX. In addition, it was validated in the prospective Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Gradient-weighted class activation mapping was used to localize class-discriminating signals in ECG images. Results: Overall, 385,601 ECGs with paired echocardiograms were used for model development. The model demonstrated high discrimination power across various ECG image formats and calibrations in internal validation (area under receiving operation characteristics [AUROC] 0.91, area under precision-recall curve [AUPRC] 0.55), and external sets of ECG images from Cedars Sinai (AUROC 90, AUPRC 0.53), outpatient YNHH clinics (AUROC 0.94, AUPRC 0.77), LRH (AUROC 0.90, AUPRC 0.88), Memorial Hermann Southeast Hospital (AUROC 0.91, AUPRC 0.88), Methodist Cardiology Clinic (AUROC 0.90, AUPRC 0.74), and ELSA-Brasil cohort (AUROC 0.95, AUPRC 0.45). An ECG suggestive of LV systolic dysfunction portended over 27-fold higher odds of LV systolic dysfunction on TTE (OR 27.5, 95% CI, 22.3-33.9 in the held-out set). Class-discriminative patterns localized to the anterior and anteroseptal leads (V2-V3), corresponding to the left ventricle regardless of the ECG layout. A positive ECG screen in individuals with LV ejection fraction ≥ 40% at the time of initial assessment was associated with a 3.9-fold increased risk of developing incident LV systolic dysfunction in the future (HR 3.9, 95% CI 3.3-4.7, median follow-up 3.2 years). Conclusions: We developed and externally validated a deep learning model that identifies LV systolic dysfunction from ECG images. This approach represents an automated and accessible screening strategy for LV systolic dysfunction, particularly in low-resource settings. CLINICAL PERSPECTIVE: What is New?: A convolutional neural network model that accurately identifies LV systolic dysfunction from ECG images across subgroups of age, sex, and race. The model shows robust performance across multiple institutions and health settings, both applied to ECG image databases as well as directly uploaded single ECG images to a web-based application by clinicians. The approach provides information for both screening of LV systolic dysfunction and its risk based on ECG images alone. What are the clinical implications?: Our model represents an automated screening strategy for LV systolic dysfunction on a variety of ECG layouts. With availability of ECG images in practice, this approach overcomes implementation challenges of deploying an interoperable screening tool for LV systolic dysfunction in resource-limited settings. This model is available in an online format to facilitate real-time screening for LV systolic dysfunction by clinicians.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.06.04.22276000

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 23

  1. Wang, T. J. et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108, 977-982, doi:10.1161/01.CIR.0000085166.44904.79 (2003). · DOI · Paper page
  2. Srivastava, P. K. et al. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. JACC Heart Fail 9, 28-38, doi:10.1016/j.jchf.2020.08.017 (2021). · DOI · Paper page
  3. Wolfe, N. K., Mitchell, J. D. & Brown, D. L. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction. Eur Heart J Qual Care Clin Outcomes 7, 416-421, doi:10.1093/ehjqcco/qcaa032 (2021). · DOI · Paper page
  4. Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 101161CIR0000000000001063, doi:10.1161/CIR.0000000000001063 (2022). · DOI · Paper page
  5. Wang, T. J., Levy, D., Benjamin, E. J. & Vasan, R. S. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138, 907-916, doi:10.7326/0003-4819-138-11-200306030-00012 (2003). · DOI · Paper page
  6. Vasan, R. S. et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288, 1252-1259, doi:10.1001/jama.288.10.1252 (2002). · DOI · Paper page
  7. McDonagh, T. A., McDonald, K. & Maisel, A. S. Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide. Congest Heart Fail 14, 5-8, doi:10.1111/j.1751-7133.2008.tb00002.x (2008). · DOI · Paper page
  8. Galasko, G. I., Barnes, S. C., Collinson, P., Lahiri, A. & Senior, R. What is the most cost- effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27, 193-200, doi:10.1093/eurheartj/ehi559 (2006). · DOI · Paper page
  9. Atherton, J. J. Screening for left ventricular systolic dysfunction: is imaging a solution? JACC Cardiovasc Imaging 3, 421-428, doi:10.1016/j.jcmg.2009.11.014 (2010). · DOI
  10. Attia, Z. I. et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med 25, 70-74, doi:10.1038/s41591-018- 0240-2 (2019). · DOI · Paper page
  11. Vaid, A. et al. Using Deep-Learning Algorithms to Simultaneously Identify Right and Left Ventricular Dysfunction From the Electrocardiogram. JACC Cardiovasc Imaging 15, 395-410, doi:10.1016/j.jcmg.2021.08.004 (2022). · DOI
  12. Yao, X. et al. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial. Nat Med 27, 815-819, doi:10.1038/s41591-021-01335-4 (2021). · DOI · Paper page
  13. Stamenov, D., Gusev, M. & Armenski, G. in 2018 41st International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO). 0319-0323 (IEEE).
  14. Sangha, V. et al. Automated multilabel diagnosis on electrocardiographic images and signals. Nat Commun 13, 1583, doi:10.1038/s41467-022-29153-3 (2022). · DOI
  15. He, J. et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med 25, 30-36, doi:10.1038/s41591-018-0307-0 (2019). · DOI · Paper page
  16. Mingxing Tan and Quoc V Le. EfficientNet: Rethinking model scaling for convolutional neural networks. International Conference on Machine Learning, 2019.
  17. Siontis, K. C., Noseworthy, P. A., Attia, Z. I. & Friedman, P. A. Artificial intelligence- enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol 18, 465-478, doi:10.1038/s41569-020-00503-2 (2021). · DOI · Paper page
  18. Quer, G., Arnaout, R., Henne, M. & Arnaout, R. Machine Learning and the Future of Cardiovascular Care: JACC State-of-the-Art Review. J Am Coll Cardiol 77, 300-313, doi:10.1016/j.jacc.2020.11.030 (2021). · DOI
  19. Maurovich-Horvat, P. Current trends in the use of machine learning for diagnostics and/or risk stratification in cardiovascular disease. Cardiovasc Res 117, e67-e69, doi:10.1093/cvr/cvab059 (2021). · DOI
  20. Pellikka, P. A. et al. Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. JAMA Netw Open 1, e181456, doi:10.1001/jamanetworkopen.2018.1456 (2018). · DOI · Paper page
  21. Jenkins, C. et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 30, 98-106, doi:10.1093/eurheartj/ehn484 (2009). · DOI · Paper page
  22. Cui, Y., Jia, M., Lin, T.-Y., Song, Y. & Belongie, S. Class-Balanced Loss Based on Effective Number of Samples. arXiv:1901.05555 (2019). <https://ui.adsabs.harvard.edu/abs/2019arXiv190105555C>. · arXiv
  23. Selvaraju, R. R. et al. Grad-CAM: Visual Explanations from Deep Networks via Gradient-based Localization. Ieee I Conf Comp Vis, 618-626, doi:10.1109/Iccv.2017.74 (2017). · DOI · Paper page

Cited by

Sorted by citations

Authors
Sangha, V., Nargesi, A. A., Dhingra, L. S., Khunte, A., Mortazavi, B. J., Ribeiro, A. H., Banina, E., Adeola, O., Garg, N., Brandt, C. A., Miller, E. J., Ribeiro, A. L. J., Velazquez, E. J., Giatti, L., Barreto, S. M., Foppa, M., Yuan, N., Ouyang, D., Krumholz, H. M., & Khera, R.
Affiliations
  • Yale University (US)
  • Brigham and Women's Hospital (US)
  • Yale New Haven Hospital (US)
  • Universidade Federal de Minas Gerais (BR)
  • Lake Regional Hospital (US)
  • Methodist Healthcare (US)
  • Memorial Hermann (US)
  • Universidade Federal do Rio Grande do Sul (BR)
  • San Francisco VA Medical Center (US)
  • Cedars-Sinai Medical Center (US)
Corresponding author
Khera, Rohan
Venue
Circulation
Publisher
openRxiv
Published
2022-06-06
Volume
148
Issue
9
Pages
765-777
ISSN
0009-7322 (ISSN-L)
OpenAlex
W4385230416
Cited by
150
References
0
Citations by year
2026: 48 · 2025: 53 · 2024: 37 · 2023: 12
FWCI
29.52
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Circulation (publishedVersion)
  • medRxiv (acceptedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Department of Defense
  • Bristol-Myers Squibb
  • Yale University
  • Shenzhen Center for Health Information
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Novo Nordisk
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • National Institutes of Health
  • Advanced Research Projects Agency
  • National Heart, Lung, and Blood Institute (K23HL153775)
  • National Institute of Biomedical Imaging and Bioengineering
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
left ventricular systolic dysfunction, ECG images, 12-lead ECG, deep learning, convolutional neural networks, left ventricular ejection fraction, heart failure screening, automated screening, Grad-CAM, resource-limited settings
MeSH terms
Adult, Electrocardiography, Humans, Longitudinal Studies, Prospective Studies, Ventricular Function, Left, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review